суббота, 23 января 2016 г.

Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer

Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer


's stock had its "outperform" rating restated by equities research analysts at Oppenheimer in a research report issued to clients and investors on Friday, MarketBeat reports. They currently have a $4.00 price objective on the biotechnology company's stock.



from Biotech News